Breye Therapeutics
About:
Breye Therapeutics, a biopharmaceutical firm that provide cutting-edge oral treatments for the management of retinal vascular diseases.
Website: https://breyetx.com
Top Investors: Novo Holdings, Vaekstfonden, Innovation Fund Denmark, BioInnovation Institute, Sound Bioventures
Description:
Breye Therapeutics, a Danish-based biopharmaceutical firm in the clinical stages, is working to provide cutting-edge oral treatments for the management of retinal vascular diseases.
Total Funding Amount:
4M EUR
Headquarters Location:
Denmark, South Carolina, United States
Founded Date:
2015-01-01
Founders:
Ulrik Mouritzen
Number of Employees:
11-50
Last Funding Date:
2022-11-10
IPO Status:
Private
Industries:
© 2025 bioDAO.ai